Abstract

Common neurodegenerative proteinopathies, such as Alzheimer’s disease (AD) and Parkinson’s disease (PD), are characterized by the misfolding and aggregation of toxic protein species, including the amyloid beta (Aß) peptide, microtubule-associated protein Tau (Tau), and alpha-synuclein (αSyn) protein. These factors also show toxicity in Drosophila; however, potential limitations of prior studies include poor discrimination between effects on the adult versus developing nervous system and neuronal versus glial cell types. In addition, variable expression paradigms and outcomes hinder systematic comparison of toxicity profiles. Using standardized conditions and medium-throughput assays, we express human Tau, Aß or αSyn selectively in neurons of the adult Drosophila retina and monitor age-dependent changes in both structure and function, based on tissue histology and recordings of the electroretinogram (ERG), respectively. We find that each protein causes a unique profile of neurodegenerative pathology, demonstrating distinct and separable impacts on neuronal death and dysfunction. Strikingly, expression of Tau leads to progressive loss of ERG responses whereas retinal architecture and neuronal numbers are largely preserved. By contrast, Aß induces modest, age-dependent neuronal loss without degrading the retinal ERG. αSyn expression, using a codon-optimized transgene, is characterized by marked retinal vacuolar change, progressive photoreceptor cell death, and delayed-onset but modest ERG changes. Lastly, to address potential mechanisms, we perform transmission electron microscopy (TEM) to reveal potential degenerative changes at the ultrastructural level. Surprisingly, Tau and αSyn each cause prominent but distinct synaptotoxic profiles, including disorganization or enlargement of photoreceptor terminals, respectively. Our findings highlight variable and dynamic properties of neurodegeneration triggered by these disease-relevant proteins in vivo, and suggest that Drosophila may be useful for revealing determinants of neuronal dysfunction that precede cell loss, including synaptic changes, in the adult nervous system.Electronic supplementary materialThe online version of this article (doi:10.1186/s40478-016-0333-4) contains supplementary material, which is available to authorized users.

Highlights

  • Alzheimer’s disease (AD) [46] and Parkinson’s disease (PD) [32] are common and incurable neurodegenerative disorders responsible for substantial cognitive and/or motor disability in the aging population

  • The transgenic models utilized for this comparative study take advantage of the GAL4-UAS system [7], in which cDNAs encoding human Tau (0N4R isoform), the Aß42 peptide, or full-length αSyn protein are under control of the heterologous yeast Upstream Activating Sequence (UAS) promoter element and responsive to driver lines expressing the GAL4 transcription factor

  • We report on parallel, systematic assessments of both structural and functional changes occurring in the Drosophila retina following expression of human Tau, Aß, and αSyn under identical conditions

Read more

Summary

Introduction

Alzheimer’s disease (AD) [46] and Parkinson’s disease (PD) [32] are common and incurable neurodegenerative disorders responsible for substantial cognitive and/or motor disability in the aging population. Both disorders are characterized at autopsy by widespread neuronal loss within the central. AD and PD are characterized by a prolonged, insidious onset in which absent or subtle symptoms precede more severe cognitive and motor disability and clinical recognition. Clinicopathologic studies of PD suggest dopaminergic terminal dysfunction precedes nigral cell death [29], potentially contributing to early clinical manifestations of disease. A current priority is to develop strategies to identify affected individuals earlier allowing potential therapeutic intervention before irreversible cell death [54]

Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.